# Study of NPO-11 in Patients Undergoing Gastrointestinal Endoscopy

> **NCT03263910** · PHASE3 · COMPLETED · sponsor: **Nihon Pharmaceutical Co., Ltd** · enrollment: 220 (actual)

## Conditions studied

- Patients Undergoing Gastrointestinal Endoscopy

## Interventions

- **DRUG:** NPO-11
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT03263910
- **Lead sponsor:** Nihon Pharmaceutical Co., Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-08-21
- **Primary completion:** 2018-08-10
- **Final completion:** 2018-08-17
- **Target enrollment:** 220 (ACTUAL)
- **Last updated:** 2018-08-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03263910

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03263910, "Study of NPO-11 in Patients Undergoing Gastrointestinal Endoscopy". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03263910. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*